BYBeyza Yılmaz

Beyza Yılmaz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Beyza Yılmaz has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Timing‐dependent protective and therapeutic effects of ethyl pyruvate in trinitrobenzene sulfonic acid‐induced experimental colitis

    by Hatice Yorulmaz, Elif Yorulmaz, Elif Özkök, Suat Hayri Küçük, Erdem Sünger, Ayyub Ebrahimi, Beyza Yılmaz, Serdar Altınay

    Ulcerative colitis (UC) involves excessive inflammation, extracellular matrix remodelling and oxidative stress. Ethyl pyruvate (EP) exhibits anti‐inflammatory effects, but the comparative efficacy of prophylactic versus therapeutic administration and timing‐dependent molecular responses remains unclear. The objective of this work was to evaluate timing‐dependent protective and therapeutic effects of EP in trinitrobenzene sulfonic acid (TNBS)‐induced experimental colitis, focusing on inflammatory mediators, matrix metalloproteinases (MMPs), oxidative status and gene expression. Rats were randomly assigned to Control, EP, Colitis, Pre‐colitis (EP before TNBS) and Post‐colitis (EP after TNBS) groups. Colonic injury was assessed macroscopically and histopathologically. Tissue levels of matrix metalloproteinase (MMP)‐2, MMP‐9, interleukin (IL)‐1, IL‐17, IL‐10, nuclear factor‐κB (NF‐κB), inducible nitric oxide synthase (iNOS) and total antioxidant capacity (TAC) were measured using ELISA kits. Gene expression of MMP‐9, cytokines, NF‐κB, high mobility group box 1 (HMGB1), iNOS and interferon‐γ was analysed by quantitative real‐time PCR. TNBS induced severe colonic injury with upregulation of pro‐inflammatory cytokines, NF‐κB signalling, MMP‐2/9 and oxidative imbalance ( P  < 0.01). EP attenuated tissue damage in both prophylactic and therapeutic settings. Post‐colitis (therapeutic) EP administration produced greater suppression of MMP‐2, MMP‐9, NF‐κB, HMGB1 and iNOS, along with superior restoration of TAC ( P  < 0.05), indicating timing‐dependent modulation of inflammatory and matrix degradation pathways. EP exerts both preventive and therapeutic effects in TNBS‐induced colitis by suppressing inflammatory signalling, regulating extracellular matrix remodelling and enhancing antioxidant defences. Therapeutic administration is more effective than prophylactic treatment, highlighting the importance of timing in optimizing EP's efficacy in inflammatory bowel disease.

  • Open Access

    Boron‐Enhanced Mitochondrial Repair: DeepA‐I Tissue Regeneration

    by Beyza Yılmaz, Basak Dalbayrak, Mustafa Kucukali, Pinar Uysal Onganer, Elif Damla Arısan

    Cellular metabolism is a key regulator of tissue repair and regeneration, with mitochondrial function playing a central role in energy production and cellular homeostasis. Dysfunctional mitochondria, often due to excessive reactive oxygen species (ROS), contribute to oxidative stress, impaired wound healing, and chronic inflammation. This study investigates the therapeutic potential of DeepA‐I, a Boron‐enriched compound, in enhancing mitochondrial health, reducing oxidative damage, and promoting cellular repair in human umbilical vein endothelial cells (HUVEC) and mouse embryonic fibroblasts (MEF). Boron quantification via inductively coupled plasma optical emission spectroscopy (ICP‐OES) confirmed its presence in DeepA‐I. Cytotoxicity assessment (MTT assay) demonstrated its safety, while fluorescence microscopy (DAPI, MitoSPY, DCFDA) revealed reduced ROS levels and preserved mitochondrial integrity. A scratch assay showed accelerated cell migration and wound closure in DeepA‐I‐treated cells. Western blot analysis indicated the downregulation of Akt (a proliferation marker) and the upregulation of NRF2, a key regulator of oxidative stress resistance, without affecting apoptosis‐related proteins. These results suggest that DeepA‐I, via its Boron‐mediated mechanisms, enhances mitochondrial function, mitigates ROS‐induced damage, and improves tissue repair, positioning it as a promising therapeutic candidate for inflammatory and degenerative conditions.